Archivo de palabras clave para: Tumor cerebral
Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Aktuelles, IOZK VeröffentlichungenStefaan van Gool es editor de un número especial del Journal of Molecular Sciences
/in Brain Tumors in Children, IOZK Aktuelles, IOZK VeröffentlichungenConferencia IOZK: Electrohipertermia modulada en niños con DIPG, conferencia ESHO, Charité Berlin
/in IOZK bei Fachtagungen, IOZK MeldungenArtículo sobre Stefaan Van Gool como neurooncólogo pediátrico en el Washington Post
/in IOZK In der Presse
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
El IOZK
La inmunoterapia IOZK
Noticias y publicaciones internacionales
- The Complexity of Malignant Glioma Treatment
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature